Locations:
Search IconSearch
April 15, 2024/Neurosciences/Podcast

Balancing Benefits and Pitfalls of Neurotoxin Injections (Podcast)

Determining the right dose and injecting in the right muscle can be challenging

Indications for neurotoxin injections continue to expand, with clinicians using them to treat everything from migraine to hyperactive bladder. However, there are pitfalls associated with neurotoxin delivery.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Botulinum toxin injection is a very individualized treatment,” says Hubert Fernandez, MD, Director of Cleveland Clinic’s Center for Neurological Restoration. “It only works if it’s at the right dose and in the right muscle and for the right indication. This is a treatment where the art truly blends with the science, and therefore patients should really find the most comfortable and clinically trained injector.”

In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Fernandez and Francois Bethoux, MD, Chair of the Department of Physical Medicine and Rehabilitation, share their experiences treating patients with neurologic disorders using botulinum toxin injections. They discuss:

  • Various FDA-approved neurotoxins and their mechanisms of action
  • Neurologic disorders commonly treated with botulinum toxin injections
  • Who makes a good candidate for neurotoxin injections, and how to select the right formulation
  • Potential risks, such as weakness and other unwanted side effects
  • What’s on the horizon, including longer-acting toxins and combinations with other treatments

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™ and ANCC contact hours. After listening to the podcast, you can claim your credit here.

Excerpt from the podcast

Podcast host Glen Stevens, DO, PhD: Do you use EMG for placement of your botulinum toxin?

Advertisement

Dr. Bethoux: Yes, it's recommended by the FDA and now it's widely accepted in the field that the injections are safer and more accurate if we use some form of guidance. So it can be EMG or it can be electrical stimulation where we stimulate the muscle to see it contract before we inject it. Another mode of guidance that has gained a lot of traction is ultrasound. So we literally visualize the muscle and we can visualize the botulinum toxin going into the muscle, which really guarantees 100% accuracy in the injection.

Dr. Hubert Fernandez: Yes, in our field I would say some still do anatomical localization, meaning no external guidance other than the anatomical landmarks of the body. I think that might be okay for some indications. But it is the clinician’s preference. At our center we do, at the very least, EMG-guided botulinum toxin. So the muscle involved emits a certain sound, and when we hear that sound, then we are assured that this is the right muscle and we inject. But even better than hearing, at least in my opinion, is seeing the muscle itself and seeing the needle and seeing the botulinum toxin spread within that muscle. And so for my own practice, I have mainly transitioned to ultrasound-guided botulinum toxin injections, but this is not for everyone. There is some technical expertise and a little bit of lag time that is required for ultrasound-guided botulinum toxin injections. So it takes some practice before one becomes efficient with it.

Advertisement

Related Articles

illustration of human brain with rumor at top right
March 23, 2026/Neurosciences/Brain Tumor

Adding Eflornithine to Lomustine Extends Survival in Recurrent IDH-Mutant Grade 3 Astrocytoma

Phase 3 STELLAR trial underscores role of molecular stratification in glioma care

brain MRI taken from the back of the head
March 20, 2026/Neurosciences/Epilepsy

Unmasking the ‘Tethered’ Temporal Lobe: New MRI Metrics Improve Detection of Encephaloceles in Refractory Epilepsy

Early identification of temporal encephaloceles can improve surgical decision-making

brain scan with white lesion on right side

ARISE II Recommendations Chart a Course for Advancing Intracranial Hemorrhage Care

Academia, industry and government leaders develop consensus priorities

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

histopathology image with pink background and arrow pointing to round cell

New Insights on α-Synuclein Pathology and Clinical Phenotypes in Dementia With Lewy Bodies

The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis

MRI of the brain against black background

Advanced Neuroimaging and Clinical Perseverance Make Sense of a 68-Year-Old’s Progressive Symptoms

A case study in pairing imaging acumen with subspecialty expertise to yield answers and symptom relief

brain scan with colored dots over a dark gray region
March 3, 2026/Neurosciences/Epilepsy

Decoding the Insula: New Semiological Insights for Localizing Seizure Onset

Guidance from the largest cohort of SEEG-confirmed insular epilepsy patients reported to date

Photo of Dr. Ford
March 2, 2026/Neurosciences/Podcast

Neuroethics Conversations: Guidelines for Care (Podcast)

Ethical guidance provides guardrails so medical advances benefit patients

Ad